University of Alberta

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ualberta.ca

Clinical Trials

Physical Activity in Renal Disease (PAIRED): The Effect on Hypertension

Phase 3

Terminated

Conditions: Chronic Kidney Diseases

Interventions: Behavioral: Exercise
Other: Enhanced usual care

First Posted Date: 2018-06-11

Last Posted Date: 2021-04-30

Lead Sponsor: University of Alberta

Target Recruit Count: 44

Registration Number: NCT03551119

Locations: 🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada
🇨🇦
University of Alberta Hospital, outpatient dialysis unit, Edmonton, Alberta, Canada
🇨🇦
Grey Nuns Hospital, Edmonton, Alberta, Canada

Evaluation of Routinely Measured Patient-reported Outcomes in Hemodialysis Care

Not Applicable

Active, not recruiting

Conditions: Chronic Kidney Disease Requiring Chronic Dialysis

Interventions: Other: PROMs Assessment

First Posted Date: 2018-05-24

Last Posted Date: 2025-01-07

Lead Sponsor: University of Alberta

Target Recruit Count: 3977

Registration Number: NCT03535922

Locations: 🇨🇦
Alberta Kidney Care - South, Calgary, Alberta, Canada
🇨🇦
Alberta Kidney Care - North, Edmonton, Alberta, Canada
🇨🇦
Ontario Renal Network, Toronto, Ontario, Canada

The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane

Phase 2

Completed

Conditions: Rotator Cuff Injury
Anesthesia; Functional

Interventions: Drug: Ropivacaine
Drug: Normal saline

First Posted Date: 2018-05-23

Last Posted Date: 2022-05-24

Lead Sponsor: University of Alberta

Target Recruit Count: 27

Registration Number: NCT03533452

Locations: 🇨🇦
Sturgeon Community Hospital, St. Albert, Alberta, Canada
🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

Phase 4

Terminated

Conditions: HIV-1-infection

Interventions: Drug: B/F/TAF
Drug: Atripla
Drug: Atripla Placebo
Drug: B/F/TAF Placebo

First Posted Date: 2018-05-22

Last Posted Date: 2022-12-14

Lead Sponsor: University of Alberta

Target Recruit Count: 28

Registration Number: NCT03532425

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes

Not Applicable

Completed

Conditions: Atherosclerosis
Complications of Diabetes Mellitus

Interventions: Radiation: 18Fluoride-Sodium Fluoride radio-isotope

First Posted Date: 2018-05-21

Last Posted Date: 2018-05-21

Lead Sponsor: University of Alberta

Target Recruit Count: 98

Registration Number: NCT03530176

Locations: 🇨🇦
University Hospital of Alberta, Edmonton, Alberta, Canada

Motivation to Change Lifestyle Habits in Youth With Obesity

Completed

Conditions: Pediatric Obesity
Motivational Interviewing

First Posted Date: 2018-05-17

Last Posted Date: 2022-05-31

Lead Sponsor: University of Alberta

Target Recruit Count: 54

Registration Number: NCT03527394

Locations: 🇨🇦
Stollery Children's Hospital (Pediatric Centre for Weight and Health), Edmonton, Alberta, Canada
🇨🇦
Alberta Children's Hospital (Pediatric Centre for Weight and Health), Calgary, Alberta, Canada

Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure

Phase 2

Completed

Conditions: Congestive Heart Failure Chronic

Interventions: Drug: Resveratrol
Drug: Placebo

First Posted Date: 2018-05-15

Last Posted Date: 2023-01-12

Lead Sponsor: University of Alberta

Target Recruit Count: 13

Registration Number: NCT03525379

Locations: 🇨🇦
Alberta Cardiovascular and Stroke Research Centre, Edmonton, Alberta, Canada

Doxycycline to Protect Heart Muscle After Heart Attacks

Phase 2

Recruiting

Conditions: Heart Failure
ST Segment Elevation Myocardial Infarction

Interventions: Drug: Doxycycline Hyclate
Drug: Placebo

First Posted Date: 2018-04-25

Last Posted Date: 2025-02-04

Lead Sponsor: University of Alberta

Target Recruit Count: 170

Registration Number: NCT03508232

Locations: 🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada

Rewilding the Human Gut: Reintroduction of the Species Limosilactobacillus Reuteri

Not Applicable

Completed

Conditions: Microbial Colonization

Interventions: Other: L. Reuteri DSM20016T Strain
Other: Placebo
Other: L Reuteri PB-W1 Strain
Other: Non-Industrialized-Type Diet

First Posted Date: 2018-04-18

Last Posted Date: 2022-08-11

Lead Sponsor: University of Alberta

Target Recruit Count: 30

Registration Number: NCT03501082

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

Music Use for Sedation In Critically Ill Children

Not Applicable

Completed

Conditions: Music Therapy
Analgesia
Ventilators, Mechanical
Critical Care

Interventions: Other: Music

First Posted Date: 2018-04-13

Last Posted Date: 2019-05-13

Lead Sponsor: University of Alberta

Target Recruit Count: 60

Registration Number: NCT03497559

Locations: 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy